UBS Group
STTK icon

UBS Group’s Shattuck Labs STTK Stock Holding History

UBS Group’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Buy
57,239
+20,959
+58% +$131K ﹤0.01% 6382
2026
Q1 		$233K Buy
36,280
+23,076
+175% +$109K ﹤0.01% 6548
2025
Q4 		$48.2K Buy
13,204
+11,771
+821% +$28.1K ﹤0.01% 7236
2025
Q3 		$3.42K Sell
1,433
-266,938
-99% -$327K ﹤0.01% 9050
2025
Q2 		$213K Buy
268,371
+117,221
+78% +$114K ﹤0.01% 6676
2025
Q1 		$144K Buy
151,150
+36,798
+32% +$45.3K ﹤0.01% 6770
2024
Q4 		$138K Sell
114,352
-110,414
-49% -$137K ﹤0.01% 6680
2024
Q3 		$784K Buy
224,766
+212,905
+1,795% +$794K ﹤0.01% 4865
2024
Q2 		$45.8K Buy
11,861
+8,966
+310% +$72.9K ﹤0.01% 6759
2024
Q1 		$25.9K Buy
+2,895
New +$26.5K ﹤0.01% 6802
2023
Q4 		– Sell
-114
Closed -$173 – 9859
2023
Q3 		$173 Sell
114
-200
-64% -$457 ﹤0.01% 8746
2023
Q2 		$980 Sell
314
-10,664
-97% -$30.9K ﹤0.01% 8048
2023
Q1 		$32.3K Buy
10,978
+4,214
+62% +$14.9K ﹤0.01% 6744
2022
Q4 		$15.6K Buy
6,764
+1,231
+22% +$3.08K ﹤0.01% 7965
2022
Q3 		$15K Buy
5,533
+5,362
+3,136% +$20.1K ﹤0.01% 7827
2022
Q2 		$1K Buy
+171
New +$619 ﹤0.01% 9960
2022
Q1 		– Sell
-9,179
Closed -$78K – 10867
2021
Q4 		$78K Buy
9,179
+9,130
+18,633% +$126K ﹤0.01% 6520
2021
Q3 		$1K Buy
+49
New +$1.05K ﹤0.01% 9242
2021
Q2 		– Sell
-18,181
Closed -$532K – 9805
2021
Q1 		$532K Buy
18,181
+16,061
+758% +$675K ﹤0.01% 4819
2020
Q4 		$111K Buy
+2,120
New +$68.1K ﹤0.01% 5625

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group's STTK Position: Q2 2026 in Review

UBS Group increased its Shattuck Labs (STTK) stake by 58% in Q2 2026, buying an estimated $131K and bringing the position to 57,239 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #6382.

UBS Group first reported a position in STTK in Q4 2020 and has held it in 20 quarters since. The position peaked at $784K in Q3 2024. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • UBS Group held 57,239 shares of Shattuck Labs worth $397K as of Q2 2026.
  • UBS Group bought 20,959 Shattuck Labs shares in Q2 2026, an estimated $131K.
  • Shattuck Labs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6382 holding.
  • UBS Group first reported a position in Shattuck Labs in Q4 2020 and has held it in 20 quarters since.
  • UBS Group's Shattuck Labs position peaked at $784K in Q3 2024.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.